Testing effectiveness (Phase 2)Study completedNCT01599637
What this trial is testing
Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment
Who this might be right for
Chronic Idiopathic Urticaria
Novartis Pharmaceuticals 40